EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Diagnosis and Management of Adult Malignancy-Associated Hemophagocytic Lymphohistiocytosis

Jerry C Lee, Aaron C Logan iD

Cancers · 18.03.2023 · 15 (6) · 1839

DOI: 10.3390/cancers15061839 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 18.03.2023. Verfasst von Jerry C Lee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, Division of Hematology/Oncology, University of California, San Francisco,…. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of severe, dysregulated inflammation driven by the inability of T cells to clear an antigenic target. When associated with malignancy (mHLH), the HLH syndrome is typically associated with extremely poor survival. Here, we review the diagnosis of secondary HLH (sHLH) syndromes in adults, with emphasis on the appropriate workup and treatment of mHLH. At present, the management of HLH in adults, including most forms of mHLH, is based on the use of corticosteroids and etoposide following the HLH-94 regimen. In some cases, this therapeutic approach may be cohesively incorporated into malignancy-directed therapy, while in other cases, the decision about whether to treat HLH prior to initiating other therapies may be more complicated. Recent studies exploring the efficacy of other agents in HLH, in particular ruxolitinib, offer hope for better outcomes in the management of mHLH. Considerations for the management of lymphoma-associated mHLH, as well as other forms of mHLH and immunotherapy treatment-related HLH, are discussed.

Schlagwörter

Stichwörter der Autor:innen

HLHLAHShemophagocytic lymphohistiocytosishemophagocytosismHLHruxolitinib

Autor:innen und Institutionen

  • Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, Division of Hematology/Oncology, University of California, San Francisco, CA 94143, USA.

ORCID-Profile: Aaron C Logan

Zitieren

APA

Lee, J. C., & Logan, A. C. (2023). Diagnosis and Management of Adult Malignancy-Associated Hemophagocytic Lymphohistiocytosis. Cancers, 15(6), 1839. https://doi.org/10.3390/cancers15061839

Vancouver

Lee JC, Logan AC. Diagnosis and Management of Adult Malignancy-Associated Hemophagocytic Lymphohistiocytosis. Cancers. 2023;15(6):1839. doi:10.3390/cancers15061839

BibTeX
@article{Lee2023,
  author = {Lee, Jerry C and Logan, Aaron C},
  title = {Diagnosis and Management of Adult Malignancy-Associated Hemophagocytic Lymphohistiocytosis},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {6},
  pages = {1839},
  doi = {10.3390/cancers15061839}
}
Kostenlos starten →